Trevi Therapeutics Inc (TRVI)

0.85 -0.05  -5.37% NASDAQ Dec 6, 13:18 USD
View Full Chart
Price Chart
View All TRVI News

News

View All Events

Events

Date Type Description
03/25/2022 Earnings Results Q4 2021 Earnings Results
03/25/2022 16:30 EST Earnings Calls Q4 2021 Earnings Call
11/10/2021 Earnings Results Q3 2021 Earnings Results
11/10/2021 16:30 EST Earnings Calls Q3 2021 Earnings Call
08/12/2021 Earnings Results Q2 2021 Earnings Results
08/12/2021 16:30 EST Earnings Calls Q2 2021 Earnings Call
06/16/2021 09:00 EST AGM 2021 Annual General Meeting
05/13/2021 Earnings Results Q1 2021 Earnings Results
05/13/2021 16:30 EST Earnings Calls Q1 2021 Earnings Call
03/25/2021 Earnings Results Q4 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions. It is involved in developing nalbuphine ER for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis, or IPF, and levodopa-induced dyskinesia, or LID, in patients with Parkinson's disease.
  • URL: https://www.trevitherapeutics.com
  • Investor Relations URL: N/A
  • HQ State/Province: Connecticut
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Value
  • Next Earnings Release: Mar. 25, 2022
  • Last Earnings Release: Nov. 10, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.